D-0018-2015 Class III Terminated
FDA drug recall D-0018-2015 was initiated by Valeant Pharmaceuticals North America LLC on May 21, 2014 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset The recall status is terminated (terminated Aug 4, 2015). Affected quantity: 205,853 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 22, 2014
- Initiation Date
- May 21, 2014
- Termination Date
- Aug 4, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 205,853 bottles
Product description
Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada
Reason for recall
Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset
Distribution pattern
Nationwide
Code information
VASERETIC 10-25MG TAB 100CT Lot # 12J022P exp. 9/30/2014 VASERETIC 10-25MG TAB 100CT Lot # 13G047P exp. 07/31/2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0018-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026